SCHEMBL5664154

SCHEMBL5664154

CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 6/20 0.72
PSEN2 P49810 6/20 0.72
APH1B Q8WW43 6/20 0.72
NCSTN Q92542 6/20 0.72
APH1A Q96BI3 6/20 0.72
PSENEN Q9NZ42 6/20 0.72
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
TRPV4 Q9HBA0 1/20 0.43
HTT P42858 1/20 0.43
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PKM P14618 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4824197 0.91 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5641977 0.90 PSEN1 (0.71) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5665980 0.89 PSEN1 (0.75) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5191782 0.88 PSEN1 (0.62) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5195898 0.87 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5190957 0.86 PSEN1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5195448 0.86 PSEN1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5641954 0.85 PSEN1 (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5193632 0.85 PSEN1 (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5190731 0.85 PSEN1 (0.80) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613614-A2 DI-ARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Merck & Co., Inc. (US) 2006-01-11 EP claimed
WO-2004089303-A2 DI-ARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2004-10-21 WO claimed
US-7161006-B2 Sulphones for inhibition of gamma secretase MERCK SHARP & DOHME LIMITED (GB) 2007-01-09 US disclosed
US-20050261276-A1 Novel sulphones for inhibition of gamma secretase MERCK SHARP & DOHME LTD. (GB) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261276-A1 Novel sulphones for inhibition of gamma secretase BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 5/4885APH1B 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.